DOI: 10.1056/NEJMoa2306963 [Google Scholar] Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hanselmann A, et al
Healthcare providers should work closely with patients to weigh the potential risks and benefits of GLP-1 therapy and tailor treatment plans to individual needs and preferences
Low Blood Sugar and Retatrutide: Risks, Symptoms, and Safe Management Low blood sugar (hypoglycaemia) is an important safety consideration for anyone taking retatrutide, an investigational triple receptor agonist currently being evaluated in clinical trials
They will assess the severity of the itching and determine the best course of action, which may include adjusting the dosage or switching medications
For successful product reformulations, manufacturers need to consider nutritional, functional, and organoleptic properties of ingredients for the best, craveable outcomes
References Pickart, L